Moderna enrols first patient in Phase I/II trial of mRNA-3704
Moderna’s mRNA-3704 will be administered via intravenous infusion in patients with isolated MMA. Credit: Arek Socha from Pixabay.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
-
CSM, a Clinigen company
CSM, a Clinigen company, focuses on clinical trial supplies and...
About
CSM, a Clinigen company, focuses on clinical trial supplies and biological sample management services.
FollowMake an Enquiry
-
Jeeva Informatics Solutions
Jeeva Informatics Solutions (Jeeva) is a seed-stage start-up on a...
About
Jeeva Informatics Solutions (Jeeva) is a seed-stage start-up on a mission to develop artificial intelligence (AI)-driven decentralised clinical trials and optimise patient-focused clinical research.
FollowMake an Enquiry
-
SynapCon
SynapCon specialises in the development of innovative software solutions for...
About
SynapCon specialises in the development of innovative software solutions for clinical trial and medical research project management.
FollowMake an Enquiry